A systematic review of strategies adopted to scale up COVID-19 testing in low-, middle- and high-income countries

• Published in: BMJ open 2022-11, Vol.12 (11), p.e060838
• Main Authors: Muttamba, Winters, O'Hare, Bernadette Ann-Marie, Saxena, Vibhor, Bbuye, Mudarshiru, Tyagi, Parul, Ramsay, Andrew, Kirenga, Bruce, Sabiiti, Wilber
• Format: Article
• Language: English
• Subjects: Antigens; Coronaviruses; COVID-19; COVID-19 - diagnosis; COVID-19 diagnostic tests; COVID-19 Testing; Developed Countries; Developing Countries; Disease transmission; Global Health; health policy; High income; Humans; Income; Industrialized nations; Laboratories; LDCs; Pandemics; public health; Researchers; Severe acute respiratory syndrome coronavirus 2; Systematic review
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2022-060838

ObjectiveWe undertook a systematic review of strategies adopted to scale up COVID-19 testing in countries across income levels to identify successful approaches and facilitate learning.MethodsScholarly articles in English from PubMed, Google scholar and Google search engine describing strategies used to increase COVID-19 testing in countries were reviewed. Deductive analysis to allocate relevant text from the reviewed publications/reports to the a priori themes was done.Main resultsThe review covered 32 countries, including 11 high-income, 2 upper-middle-income, 13 lower-middle-income and 6 low-income countries. Most low- and middle-income countries (LMICs) increased the number of laboratories available for testing and deployed sample collection and shipment to the available laboratories. The high-income countries (HICs) that is, South Korea, Germany, Singapore and USA developed molecular diagnostics with accompanying regulatory and legislative framework adjustments to ensure the rapid development and use of the tests. HICs like South Korea leveraged existing manufacturing systems to develop tests, while the LMICs leveraged existing national disease control programmes (HIV, tuberculosis, malaria) to increase testing. Continent-wide, African Centres for Disease Control and Prevention-led collaborations increased testing across most African countries through building capacity by providing testing kits and training.ConclusionStrategies taken appear to reflect the existing systems or economies of scale that a particular country could leverage. LMICs, for example, drew on the infectious disease control programmes already in place to harness expertise and laboratory capacity for COVID-19 testing. There however might have been strategies adopted by other countries but were never published and thus did not appear anywhere in the searched databases.